Atlas Trials

SD-OCT-guided Intravitreal Ranibizumab Treatment in Choroidal Neovascularization Due to Myopia

Clinical trial NCT03409250 · COMPLETED

Trial details

NCT number
NCT03409250
Sponsor
Vista Klinik
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Choroidal NeovascularizationAge Related Macular Degeneration
Start date
2011-06-01
Primary completion
2014-07-01
Enrollment
20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.